Scientific breakthroughs have dramatically changed the way we treat cancer with an increasing amount of oral anti-cancer therapies becoming available. Unfortunately, outdated policies for insurance coverage haven't kept up and can force patients to pay much higher out-of-pocket costs for medicines taken orally than those intravenous (IV).
For many patients battling cancer, oral anti-cancer therapies are sometimes the only treatment option, not just the best option. Cancer patients should be able to make treatment decisions based on what is best for their health - rather than how a treatment is covered by their health insurer.
Join your voice with breast cancer advocates from across the country, and encourage your Representatives to cosponsor the Cancer Drug Parity Act to ensure anyone who has ever received a breast cancer diagnosis has access to the anti-cancer treatments they need!